A drug producer linked to the pharmacy at the center of a national meningitis outbreak announced a recall of all of its products Wednesday after federal regulators found that it had not provided enough assurance that all the medicines it made were sterile.
The company, Ameridose, which is based in Massachusetts and is a major supplier of sterile injectable medications to hospitals across the country, underscored that there had been no reports of impurities in any of its products and said that it had announced the recall “out of an abundance of caution.”
